COVID-19
The Tragic Story Of A 14-Year-Old Vaccine Myocarditis Victim — One Of Umpteen Males Misinformed By Health Authorities

Posted with permission from the author, this was originally published in Noble Truths with Rav Arora
Vaccine myocarditis is not trivial, mild, or “rare.” In young men, it’s a far greater risk than Covid hospitalization and death.
Read Part 1 and Part 2 of my investigative vaccine myocarditis series.
On May 12th of last year, school teacher Emily Jo took her 14-year-old son Aiden to get his first Pfizer vaccine dose. The public health authorities and her son’s pediatrician unanimously recommended vaccination, prompting her decision. She knew that mRNA shots caused some number of adverse events, like all vaccines, but was re-assured by the CDC and White House’s public recommendation.
“The talk amongst the mainstream medical community was that vaccine myocarditis was mild and that this was very rare,” she told me.
At that time, despite alarming heart inflammation reports from Israel, the CDC publicly claimed to have found no signal of myocarditis after “intentionally” investigating over 200 million administered doses.
Moreover, Emily Jo was never warned of the myocarditis risk or informed about the risk-benefit profile.
“When I took Aiden to get his vaccines at the drive-through vaccination site, there was no warning about myocarditis. We were not counseled about any side effects to be aware of,” she said.
In the name of public safety, scientific innovation, and personal health, Emily Jo sent out a celebratory tweet proclaiming she and her family are “so thankful” their teenage son was able to get vaccinated.
However, her pride and relief turned out to be tragically short-lived. Two days after her son’s second vaccine dose (which he got a month after his first), he ended up in the hospital after experiencing intense chest pain. He was moved to a room on the acute cardiac floor where he was found to have elevated troponin levels (a key sign of heart damage) and an abnormal electrocardiogram. Every doctor Emily Jo spoke to at the pediatric hospital Children’s Healthcare of Atlanta confirmed her son had vaccine-induced myocarditis.
Given her son’s dire condition, Emily worried Aidan might die or suffer from a catastrophic injury. Thankfully, after four distressful days at the hospital, Aidan troponin levels returned to baseline and he was discharged. However, this didn’t mean he could return to his normal life. Aidan was unable to do physical activity for six months. Sports, hikes, and other forms of exercise were deemed too dangerous for his heart — a typical consequence of myocardial injuries.
“I had no idea how life altering ‘mild’ myocarditis actually is. I have a very hard time with the label ‘mild’ for anything that requires hospitalization and months of inactivity,” Emily Jo said.
The most serious concern with Aidan’s vaccine injury isn’t the harrowing experience itself, but the frequency at which it occurs. Virtually any substance or medication will produce a diverse range of reactions across the human population. As Sam Harris has correctly noted, if you administer peanuts to everyone, there will be some number of fatalities and cases of anaphylaxis.
The rare incidence of life-threatening anomalies doesn’t mean that peanuts produce a net harm or should be banned altogether. Tragic interactions with any kind of externality are often exaggerated and exploited to justify irrational ideological agendas. For example, Minneapolis officer Derek Chauvin’s treatment of George Floyd paved the way for radical “Abolish the Police” initiatives.
In the case of COVID-19 vaccines causing myocarditis, we aren’t dealing with trivial ratios of one in a million or even one in ten thousand. Among the most robust data we have—according to Dr. Tracy Beth Hoeg (Florida Health department) and Dr. Marty Makary (Johns Hopkins University)—is from Dr. Katie Sharff (who had her young son vaccinated) and colleagues, who analyzed a wide database from Kaiser Permanente.
Dr. Vinay Prasad on the Kaiser Permanente study
Going beyond other study methods, Sharff found a number of vaccine myocarditis cases that weren’t explicitly labelled as such or were outside the parameters of the CDC’s vaccine safety search. After performing an exhaustive search of the Kaiser medical records, Sharff and colleagues found a 1 in 1,862 rate of myocarditis after the second dose in young men ages 18 to 24. For boys ages 12 to 17, the rate was 1 in 2,650. Countries with active surveillance monitoring of medical data (which suffer from far less under-reporting than the passive system in the U.S)—such as Hong Kong—show virtually identical figures. The risk of vaccine-induced myocarditis remains elevated for men up to the age of 40.

11:26 PM ∙ Jul 19, 2022
One need not be an anti-vaccine conspiracy theorist to recognize these figures are alarmingly high.
Historically, vaccines with adverse event profiles far lower — but still deemed far too high — than the mRNA myocarditis signal have been withdrawn. The 1976 swine flu vaccine was pulled back because of a 1 in 100,000 risk of Guillain-Barre Syndrome.
An approximate 1 in 3,000 risk of vaccine myocarditis in young males would only be favorable in a cost-benefit analysis wherein the risk of disease would be considerably serious.
The pre-vaccine Covid infection fatality rate for people under 30 was 0.003%.
The vaccine myocarditis risk after dose two (0.03%) is ten times higher than the fatality rate.
Today, since the vast majority of young Americans have been previously infected with Covid once or twice, the calculus has shifted. Putting aside the question of whether it makes sense for unvaccinated people to get the primary series targeting outdated variants, the myocarditis risk (in young males) from even one dose eclipses that of hospitalizations from re-infection. Josh Stevenson — a data analyst who has co-authored multiple peer-reviewed studies on vaccine myocarditis — has designed the following bar graph comparing risks:
Using Covid hospitalization statistics instead of deaths is a more accurate comparison since Covid deaths are virtually nonexistent in healthy, young populations. Still, the differences are massive. For example, the risk of myocarditis from dose one in males ages 18-24 is 15 times higher than hospitalization from Covid re-infection. For dose two, the risk differential is a stunning 61 times greater.
Unless a young male is immunocompromised, obese, or suffering from other serious health conditions, taking any mRNA Covid vaccines carries far more risk than benefit. The best data indicate this is a fact — though this is hardly considered in mainstream media.
***
Cases such as Aidan’s have prompted many honest voices in the public health community to reflect on the CDC’s top-down vaccine recommendations. Dr. Anish Koka—a renowned cardiologist with his own clinic in Philadelphia—believes medical experts should have been “more careful about recommending this to low-risk patients from the very outset.”
Koka Cardiology
As he explained to me over email, “Clinical myocarditis is never mild—a recent paper of 12–29-year-olds found 25% of myocarditis patients end up in the ICU, and 1 patient needed ECMO (a modified heart lung machine) to stay alive.”
“The long term impacts of the persistent scars that are apparent in follow-up on cardiac MRI are also unknown,” he added.
Koka believes it was “apparent by April (of 2021) there was a real safety signal,” and he questions why public health authorities “didn’t make decisions starting then to at least inform the public about this potential side effect at that point. ”
Instead of mitigating risks by further spacing vaccine doses, recommending Pfizer over Moderna, and being honest about near-zero risks of severe outcomes in younger, healthy groups, Big Pharma in collusion with the government recklessly opted for universal decrees.
Looking back on the CDC and Food and Drug Administration’s (FDA) possible negligence and recklessness, Khoka stated the harm perpetrated was “unconscionable.”
More and more medical professionals are now speaking out on the strong likelihood that vaccine-induced myocarditis seems to occur at a rate that far exceeds deaths and hospitalizations in healthy, naturally immunized men under 40. Johns Hopkins public health professor Marty Makary recently wrote in a tweet:
“Last y[ea]r, the NEJM described a 22-yr-old that died from vax-induced myocarditis & I’ve heard of many more cases. I have never heard of a young healthy person with nat[ural] immunity dying from Covid. Our gov’t doctors have not been honest about the risks:benefit in young healthy people.”
2:00 PM ∙ Sep 27, 2022
I had been frankly hesitant to make such a statement since it isn’t scientifically rigorous, but since this topic is becoming less taboo, I will say it now: I have heard (without deliberately seeking) of several vaccine myocarditis cases in healthy, young people but have heard of zero hospitalizations and deaths.
This observation is in line with real-world statistics. According to UK databefore Omicron—when the virus was deadlier—the COVID-19 death rate was just over 0.001 percent in unvaccinated 30-year-olds. For unvaccinated people in their 20s, the risk was more like 0.0001 percent. Hospitalization figures (from, not with COVID-19) are similarly infinitesimally low. Compare that with a vaccine myocarditis risk of 0.03 percent in young men.
It makes little coherent sense why young males were not only permitted and recommended to get the mRNA vaccine series, but mandated by the state (as I wrote at length here). This injustice is even more egregious now that we know vaccines confer little to no long-term protection against infection.
Aidan’s mother recently came across a new scientific paper showing dismal vaccine efficacy in adolescents and tweeted the following:
Thinking about the fact that Aidan got myocarditis for 30.6% transient efficacy is pretty infuriating…This Pfizer vaccine was initially sold as 95% effective. Big change.
Fast-forward to today, Aidan is far from his physical condition before getting double-vaccinated. After advising him against even going on for a walk for the first four months post-vaccination — and eventually allowing a return to exercise after six months — Aidan’s cardiologist has cleared him for all physical activity. However, “he tires more easily and has lower endurance,” Emily says.
“He used to be able to run around and play for hours….now it’s like 20-30 minutes and he gets exhausted,” she added.
More than a year later, Aidan is still recovering from a vaccine that had little to provide him in the first place. Though some have shamed Emily for getting her son vaccinated, she is hardly to blame for trusting in taxpayer-funded health agencies whose sole function is to keep the public healthy and safe.
In light of the FDA and CDC’s outrageous push to vaccinate everyone with the new “bivalent” booster—despite explicitly “unknown” myocarditis risks—hopefully more people will wake up and re-evaluate their blind faith in institutions who have far abandoned their ostensible mission of keeping us safe and healthy.
Rav Arora is a 21-year-old, independent journalist formerly writing for top publications such as The Globe and Mail and New York Post before critically covering vaccines and state mandates. Please consider supporting his fearless journalism, focusing on tragic stories of vaccine myocarditis, by becoming a paid subscriber. Read his in-depth vaccine myocarditis series here.
Consider becoming a paid subscriber to help fund future vaccine injury investigations:
Thank you for reading Noble Truths with Rav Arora. This post is public so feel free to share it.
COVID-19
Tulsi Gabbard says US funded ‘gain-of-function’ research at Wuhan lab at heart of COVID ‘leak’

From LifeSiteNews
The director of National Intelligence revealed gain-of-function ties to US funding, which could indicate that the US helped bankroll the supposed COVID lab leak.
In this segment of a remarkable interview by Megyn Kelly, Director of National Intelligence Tulsi Gabbard discusses the current Intelligence Community (IC) research into the origin of the SARS-CoV-2 pandemic (aka, COVID-19).
Gabbard talks about the U.S. government funding of “gain-of-function” research, which is a soft sounding phrase to describe the weaponization of biological agents.
Gabbard notes the gain-of-function research taking place in the Wuhan lab was coordinated and funded by the United States government, and the IC is close to making a direct link between the research and the release of the COVID-19 virus.
Additionally, Gabbard explains the concern of other biolabs around the world and then gets very close to the line of admitting the IC itself is politically weaponized (which it is but would be stunning to admit).
COVID-19
Study finds Pfizer COVID vaccine poses 37% greater mortality risk than Moderna

From LifeSiteNews
A study of 1.47 million Florida adults by MIT’s Retsef Levi and Surgeon General Joseph Ladapo finds significantly higher all-cause mortality after Pfizer vaccination compared to Moderna
A new study of 1.47 million Florida adults by MIT’s Retsef Levi and Surgeon General Joseph Ladapo finds significantly higher all-cause, cardiovascular, and COVID-19 mortality after Pfizer vaccination.
The study titled “Twelve-Month All-Cause Mortality after Initial COVID-19 Vaccination with Pfizer-BioNTech or mRNA-1273 among Adults Living in Florida” was just uploaded to the MedRxiv preprint server. This study was headed by MIT Professor Retsef Levi, with Florida Surgeon General Dr. Joseph Ladapo serving as senior author:
Study Overview
- Population: 1,470,100 noninstitutionalized Florida adults (735,050 Pfizer recipients and 735,050 Moderna recipients).
- Intervention: Two doses of either:
- BNT162b2 (Pfizer-BioNTech)
- mRNA-1273 (Moderna)
- Follow-up Duration: 12 months after second dose.
- Comparison: Head-to-head between Pfizer vs. Moderna recipients.
- Main Outcomes:
- All-cause mortality
- Cardiovascular mortality
- COVID-19 mortality
- Non-COVID-19 mortality
All-cause mortality
Pfizer recipients had a significantly higher 12-month all-cause death rate than Moderna recipients — about 37% higher risk.
- Pfizer Risk: 847.2 deaths per 100,000 people
- Moderna Risk: 617.9 deaths per 100,000 people
- Risk Difference:
➔ +229.2 deaths per 100,000 (Pfizer excess) - Risk Ratio (RR):
➔ 1.37 (i.e., 37% higher mortality risk with Pfizer) - Odds Ratio (Adjusted):
➔ 1.384 (95% CI: 1.331–1.439)
Cardiovascular mortality
Pfizer recipients had a 53% higher risk of dying from cardiovascular causes compared to Moderna recipients.
- Pfizer Risk: 248.7 deaths per 100,000 people
- Moderna Risk: 162.4 deaths per 100,000 people
- Risk Difference:
➔ +86.3 deaths per 100,000 (Pfizer excess) - Risk Ratio (RR):
➔ 1.53 (i.e., 53% higher cardiovascular mortality risk) - Odds Ratio (Adjusted):
➔ 1.540 (95% CI: 1.431–1.657)
COVID-19 mortality
Pfizer recipients had nearly double the risk of COVID-19 death compared to Moderna recipients.
- Pfizer Risk: 55.5 deaths per 100,000 people
- Moderna Risk: 29.5 deaths per 100,000 people
- Risk Difference:
➔ +26.0 deaths per 100,000 (Pfizer excess) - Risk Ratio (RR):
➔ 1.88 (i.e., 88% higher COVID-19 mortality risk) - Odds Ratio (Adjusted):
➔ 1.882 (95% CI: 1.596–2.220)
Non-COVID-19 mortality
Pfizer recipients faced a 35% higher risk of dying from non-COVID causes compared to Moderna recipients.
- Pfizer Risk: 791.6 deaths per 100,000 people
- Moderna Risk: 588.4 deaths per 100,000 people
- Risk Difference:
➔ +203.3 deaths per 100,000 (Pfizer excess) - Risk Ratio (RR):
➔ 1.35 (i.e., 35% higher non-COVID mortality risk) - Odds Ratio (Adjusted):
➔ 1.356 (95% CI: 1.303–1.412)
Biological explanations
The findings of this study are surprising, given that Moderna’s mRNA-1273 vaccine contains approximately three times more mRNA (100 µg) than Pfizer’s BNT162b2 vaccine (30 µg). This suggests that the higher mortality observed among Pfizer recipients could potentially be related to higher levels of DNA contamination — an issue that has been consistently reported worldwide:
The paper hypothesizes differences between Pfizer and Moderna may be due to:
- Different lipid nanoparticle compositions
- Differences in manufacturing, biodistribution, or storage conditions
Final conclusion
Florida adults who received Pfizer’s BNT162b2 vaccine had higher 12-month risks of all-cause, cardiovascular, COVID-19, and non-COVID-19 mortality compared to Moderna’s mRNA-1273 vaccine recipients.
Unfortunately, without an unvaccinated group, the study cannot determine the absolute increase in mortality risk attributable to mRNA vaccination itself. However, based on the mountain of existing evidence, it is likely that an unvaccinated cohort would have experienced much lower mortality risks. It’s also important to remember that Moderna mRNA injections are still dangerous.
As the authors conclude:
These findings are suggestive of differential non-specific effects of the BNT162b2 and mRNA-1273 COVID-19 vaccines, and potential concerning adverse effects on all-cause and cardiovascular mortality. They underscore the need to evaluate vaccines using clinical endpoints that extend beyond their targeted diseases.
Epidemiologist and Foundation Administrator, McCullough Foundation
Please consider following both the McCullough Foundation and my personal accounton X (formerly Twitter) for further content.
Reprinted with permission from Focal Points.
-
International1 day ago
Pentagon Salivates Over ‘Expensive’ Weapons While China Races Into Future With Iron Grip Over Cheap Drone Tech
-
Crime2 days ago
Canada Blocked DEA Request to Investigate Massive Toronto Carfentanil Seizure for Terror Links
-
Business2 days ago
Top Canadian bank ditches UN-backed ‘net zero’ climate goals it helped create
-
Alberta1 day ago
Pierre Poilievre will run to represent Camrose, Stettler, Hanna, and Drumheller in Central Alberta by-election
-
COVID-192 days ago
Tulsi Gabbard says US funded ‘gain-of-function’ research at Wuhan lab at heart of COVID ‘leak’
-
Health1 day ago
RFK Jr. orders placebo safety trials for all new vaccines in major policy decision
-
Business1 day ago
Federal government’s accounting change reduces transparency and accountability
-
2025 Federal Election1 day ago
Mark Carney vows to ‘deepen’ Canada’s ties with the world, usher in ‘new economy’